Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Hypertension Drugs Companies

ID: MRFR/Pharma/1967-HCR
55 Pages
Satyendra Maurya
Last Updated: April 06, 2026
Hypertension, or high blood pressure, is a common medical condition that often requires ongoing management with antihypertensive medications.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Hypertension Drugs Market

Middle-East and Africa Hypertension Drugs Key Companies
 
Latest Middle-East and Africa Hypertension Drugs Companies Update

Pfizer partners with local distributors in Egypt and Morocco: July 2023, Pfizer announced partnerships with local distributors in Egypt and Morocco to improve access to its portfolio of antihypertensive medications, including Accuretic (lisinopril/ hydrochlorothiazide) and Zestril (lisinopril).

Novartis launches Sandoz Generics hypertension portfolio in Nigeria: June 2023, Novartis launched its Sandoz Generics portfolio of hypertension medications in Nigeria, offering affordable options for patients with limited access to branded drugs.

Sanofi expands access to Entresto (sacubitril/valsartan) in South Africa: May 2023, Sanofi secured expanded access to Entresto, a first-line treatment for heart failure with preserved ejection fraction (HFpEF), in South Africa through private insurance coverage.

List of Middle-East and Africa Hypertension Drugs Key Companies in the Market

  • Abbott (US)
  • Johnson & Johnson Services Inc. (US)
  • Novartis (Switzerland)
  • GlaxoSmithKline plc.(UK)
  • AstraZeneca (UK)
  • Bayer AG (Germany)
  • Pfizer Inc.(US)
  • Merck & Co. Inc. (US)
  • Sanofi (France)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Gilead (US)